Cardiac PPARα expression in patients with dilated cardiomyopathy

European Journal of Heart Failure

Volumn 8, Issue 3, 2006, Pages 290-294

  Schupp, Michael ^a   Kintscher, Ulrich ^a   Fielitz, Jens ^a,b   Thomas, Jennifer ^a   Pregla, Reinhard ^c   Hetzer, Roland ^c   Unger, Thomas ^a   Regitz Zagrosek, Vera ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Cardiac metabolism; Dilated cardiomyopathy; Fatty acids; Peroxisome proliferator activated receptor alpha

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; GLUCOSE TRANSPORTER 4; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENERGY YIELD; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HEART MUSCLE METABOLISM; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; ADOLESCENT; GENETICS; HEART MUSCLE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; CARDIOMYOPATHY, DILATED; CARNITINE O-PALMITOYLTRANSFERASE; FEMALE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PPAR ALPHA; RNA, MESSENGER;

EID: 33646347106     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.09.003     Document Type: Article

References (20)

1. Huss J.M., and Kelly D.P. Nuclear receptor signaling and cardiac energetics. Circ Res 95 (2004) 568-578
2. Torra I.P., Chinetti G., Duval C., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice. Curr Opin Lipidol 12 (2001) 245-254
3. Brandt J.M., Djouadi F., and Kelly D.P. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 273 (1998) 23786-23792
4. Martin G., Schoonjans K., Lefebvre A.M., Staels B., and Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J Biol Chem 272 (1997) 28210-28217
5. Barger P.M., and Kelly D.P. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 10 (2000) 238-245
6. Barger P.M., Brandt J.M., Leone T.C., Weinheimer C.J., and Kelly D.P. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest 105 (2000) 1723-1730
7. Belke D.D., Larsen T.S., Gibbs E.M., and Severson D.L. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 279 (2000) E1104-E1113
8. Bishop S.P., and Altschuld R.A. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 218 (1970) 153-159
9. Finck B.N., Lehman J.J., Leone T.C., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109 (2002) 121-130
10. Finck B.N., and Kelly D.P. Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J Mol Cell Cardiol 34 (2002) 1249-1257
11. Barger P.M., and Kelly D.P. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci 318 (1999) 36-42
12. Paolisso G., Gambardella A., Galzerano D., et al. Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism 43 (1994) 174-179
13. Taylor M., Wallhaus T.R., Degrado T.R., et al. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and. J Nucl Med 42 (2001) 55-62
14. Fielitz J., Dendorfer A., Pregla R., et al. Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure. Circulation 105 (2002) 286-289
15. Kintscher U., Lyon C., Wakino S., et al. PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4. Circ Res 91 (2002) e35-e44
16. Davila-Roman V.G., Vedala G., Herrero P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 271-277
17. Tanaka K, Sakomura Y, Matsuda N, et al. Peroxisome proliferator-activated receptors and PPAR G coactivator-1 are expressed synergetically in patients of dilated cardiomyopathy with severe left heart failure. Circulation 2002; AHA Scientific Sessions 2002, Abstract # 100184.
18. Thomas J.A., and Marks B.H. Plasma norepinephrine in congestive heart failure. Am J Cardiol 41 (1978) 233-243
19. Wallhaus T.R., Taylor M., DeGrado T.R., et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation 103 (2001) 2441-2446
20. Klotz L., Sastre M., Kreutz A., et al. Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons. J Neurochem 86 (2003) 907-916